Ignacio ANEGON
9Patents
0h-index
4Co-inventors
30Inventor score
Filing activity: Apr 1, 2015 → Jul 9, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10137181B2 | Isolated donor MHC-derived peptide and uses thereof | Physics | 0 | Active |
| US10105425B2 | Isolated donor MHC-derived peptide and uses thereof | Physics | 0 | Active |
| US12083163B2 | Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US10591465B2 | Methods and kits for labeling, detection and isolation of Foxp3+ regulatory T cells, isolated population of Foxp3+ regulatory T cells thus obtained and uses thereof | Physics | 0 | Active |
| US11090362B2 | Pharmaceutical composition comprising IL-34 and a mTOR inhibitor | Emerging Cross-Sectional Technologies | 0 | Active |
| US12146159B2 | Methods for obtaining regulatory t cells and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10155025B2 | Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34 | Emerging Cross-Sectional Technologies | 0 | Active |
| US10724001B2 | Methods for obtaining regulatory T cells and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12168694B2 | Anti-human CD45RC antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.